表紙:ヘルスケアとライフサイエンスにおけるジャーニー管理の世界市場:タイプ別、コンポーネント別、エンドユーザー別、展開別、地域別の予測(2027年まで)- COVID-19の累積的影響
市場調査レポート
商品コード
1045221

ヘルスケアとライフサイエンスにおけるジャーニー管理の世界市場:タイプ別、コンポーネント別、エンドユーザー別、展開別、地域別の予測(2027年まで)- COVID-19の累積的影響

Journey Management in Healthcare & Life Sciences Market Research Report by Type, by Component, by End-User, by Deployment, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 186 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.11円
ヘルスケアとライフサイエンスにおけるジャーニー管理の世界市場:タイプ別、コンポーネント別、エンドユーザー別、展開別、地域別の予測(2027年まで)- COVID-19の累積的影響
出版日: 2022年01月06日
発行: 360iResearch LLP
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のヘルスケアとライフサイエンスにおけるジャーニー管理の市場規模は、2020年に37億1,961万米ドルとなり、2021年には44億9,738万米ドルに達する見込みで、その後は21.84%のCAGRで推移し、2027年までには148億3,157万米ドルに達すると予想されています。

当レポートは、世界のヘルスケアとライフサイエンスにおけるジャーニー管理市場について調査しており、市場の機会や課題、促進および抑制要因、COVID-19の累積的影響、タイプ別・コンポーネント別・エンドユーザー別・展開別・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションと範囲
  • 調査対象期間
  • 通貨と価格
  • 言語
  • 制限事項
  • 前提条件
  • 利害関係者

第2章 調査手法

  • 定義:調査目的
  • 決定:調査計画
  • 準備:調査機器
  • 収集:データソース
  • 分析:データの解釈
  • 策定:データ検証
  • 公開:調査レポート
  • 繰り返し:レポートの更新

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場の洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • COVID-19の累積的影響

第6章 ヘルスケアとライフサイエンスにおけるジャーニー管理市場:タイプ別

  • 保険ジャーニー管理
  • ペイシェントジャーニー管理
  • 製品ライフサイクル管理

第7章 ヘルスケアとライフサイエンスにおけるジャーニー管理市場:コンポーネント別

  • ジャーニーアナリティクス
  • ジャーニーマッピング
  • ジャーニー編成

第8章 ヘルスケアとライフサイエンスにおけるジャーニー管理市場:エンドユーザー別

  • 医療患者
  • 医療費支払人
  • 医療機関
  • 製薬・バイオテクノロジー企業

第9章 ヘルスケアとライフサイエンスにおけるジャーニー管理市場:展開別

  • オンクラウド
  • オンプレミス

第10章 南北アメリカのヘルスケアとライフサイエンスにおけるジャーニー管理市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋のヘルスケアとライフサイエンスにおけるジャーニー管理市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ

第12章 欧州、中東・アフリカのヘルスケアとライフサイエンスにおけるジャーニー管理市場

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析:主要企業別
  • 競合シナリオ
    • 合併・買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 評価、認知、拡大

第14章 企業のユーザビリティプロファイル

  • Acoustic, L.P
  • Acxiom Ltd.
  • Applied Epic
  • Arena Solutions
  • AthenaHealth
  • Cerner
  • Cisco Systems, Inc.
  • eClinicalWorks
  • Epic
  • GMC Software AG
  • IBM Corporation
  • Indicative, Inc.
  • InSync Healthcare Solutions
  • Luma Health
  • MasterControl
  • NextGen Healthcare
  • NICE Systems Inc
  • Oracle
  • Pegasystems Inc.
  • Propel
  • Quadient SA
  • Qualio
  • Salesforce.com, inc.
  • SAP SE
  • Servion Global Solutions Ltd.
  • Vertafore, Inc.

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET: MARKET DYNAMICS
  • FIGURE 3. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2020 VS 2027 (%)
  • FIGURE 4. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2020 VS 2027 (USD MILLION)
  • FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2027
  • FIGURE 6. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY INSURANCE JOURNEY MANAGEMENT, 2018-2027 (USD MILLION)
  • FIGURE 7. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY INSURANCE JOURNEY MANAGEMENT, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 8. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY PATIENT JOURNEY MANAGEMENT, 2018-2027 (USD MILLION)
  • FIGURE 9. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY PATIENT JOURNEY MANAGEMENT, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 10. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY PRODUCT LIFECYCLE MANAGEMENT, 2018-2027 (USD MILLION)
  • FIGURE 11. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY PRODUCT LIFECYCLE MANAGEMENT, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 12. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2020 VS 2027 (%)
  • FIGURE 13. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2020 VS 2027 (USD MILLION)
  • FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2027
  • FIGURE 15. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY JOURNEY ANALYTICS, 2018-2027 (USD MILLION)
  • FIGURE 16. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY JOURNEY ANALYTICS, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 17. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY JOURNEY MAPPING, 2018-2027 (USD MILLION)
  • FIGURE 18. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY JOURNEY MAPPING, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 19. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY JOURNEY ORCHISTRATION, 2018-2027 (USD MILLION)
  • FIGURE 20. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY JOURNEY ORCHISTRATION, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 21. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2020 VS 2027 (%)
  • FIGURE 22. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2020 VS 2027 (USD MILLION)
  • FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2027
  • FIGURE 24. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY HEALTHCARE PATIENT, 2018-2027 (USD MILLION)
  • FIGURE 25. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY HEALTHCARE PATIENT, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 26. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY HEALTHCARE PAYER, 2018-2027 (USD MILLION)
  • FIGURE 27. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY HEALTHCARE PAYER, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 28. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY HEALTHCARE PROVIDER, 2018-2027 (USD MILLION)
  • FIGURE 29. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY HEALTHCARE PROVIDER, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 30. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2027 (USD MILLION)
  • FIGURE 31. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 32. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2020 VS 2027 (%)
  • FIGURE 33. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2020 VS 2027 (USD MILLION)
  • FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2027
  • FIGURE 35. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY ON-CLOUD, 2018-2027 (USD MILLION)
  • FIGURE 36. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY ON-CLOUD, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 37. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY ON-PREMISES, 2018-2027 (USD MILLION)
  • FIGURE 38. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY ON-PREMISES, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 39. AMERICAS JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 40. ARGENTINA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 41. BRAZIL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 42. CANADA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 43. MEXICO JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 44. UNITED STATES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 45. ASIA-PACIFIC JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 46. AUSTRALIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 47. CHINA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 48. INDIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 49. INDONESIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 50. JAPAN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 51. MALAYSIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 52. PHILIPPINES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 53. SINGAPORE JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 54. SOUTH KOREA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 55. TAIWAN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 56. THAILAND JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 57. EUROPE, MIDDLE EAST & AFRICA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 58. FRANCE JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 59. GERMANY JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 60. ITALY JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 61. NETHERLANDS JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 62. QATAR JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 63. RUSSIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 64. SAUDI ARABIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 65. SOUTH AFRICA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 66. SPAIN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 67. UNITED ARAB EMIRATES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 68. UNITED KINGDOM JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 69. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET: FPNV POSITIONING MATRIX
  • FIGURE 70. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 71. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 4. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY INSURANCE JOURNEY MANAGEMENT, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 5. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY PATIENT JOURNEY MANAGEMENT, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 6. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY PRODUCT LIFECYCLE MANAGEMENT, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 7. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2027 (USD MILLION)
  • TABLE 8. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY JOURNEY ANALYTICS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 9. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY JOURNEY MAPPING, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 10. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY JOURNEY ORCHISTRATION, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 11. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
  • TABLE 12. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY HEALTHCARE PATIENT, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 13. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY HEALTHCARE PAYER, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 14. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY HEALTHCARE PROVIDER, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 15. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 16. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2027 (USD MILLION)
  • TABLE 17. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY ON-CLOUD, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 18. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 19. AMERICAS JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 20. ARGENTINA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 21. BRAZIL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 22. CANADA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 23. MEXICO JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 24. UNITED STATES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 25. ASIA-PACIFIC JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 26. AUSTRALIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 27. CHINA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 28. INDIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 29. INDONESIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 30. JAPAN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 31. MALAYSIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 32. PHILIPPINES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 33. SINGAPORE JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 34. SOUTH KOREA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 35. TAIWAN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 36. THAILAND JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 37. EUROPE, MIDDLE EAST & AFRICA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 38. FRANCE JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 39. GERMANY JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 40. ITALY JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 41. NETHERLANDS JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 42. QATAR JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 43. RUSSIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 44. SAUDI ARABIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 45. SOUTH AFRICA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 46. SPAIN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 47. UNITED ARAB EMIRATES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 48. UNITED KINGDOM JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 49. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET: SCORES
  • TABLE 50. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET: BUSINESS STRATEGY
  • TABLE 51. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET: PRODUCT SATISFACTION
  • TABLE 52. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET: RANKING
  • TABLE 53. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 54. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET: MERGER & ACQUISITION
  • TABLE 55. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 56. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 57. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET: INVESTMENT & FUNDING
  • TABLE 58. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 59. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET: LICENSE & PRICING
目次
Product Code: MRR-4E27A4DF11E8

The Global Journey Management in Healthcare & Life Sciences Market size was estimated at USD 3,719.61 million in 2020 and expected to reach USD 4,497.38 million in 2021, at a CAGR 21.84% to reach USD 14,831.57 million by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Journey Management in Healthcare & Life Sciences to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Type, the market was studied across Insurance Journey Management, Patient Journey Management, and Product Lifecycle Management.
  • Based on Component, the market was studied across Journey Analytics, Journey Mapping, and Journey Orchistration.
  • Based on End-User, the market was studied across Healthcare Patient, Healthcare Payer, Healthcare Provider, and Pharmaceutical & Biotechnology Companies.
  • Based on Deployment, the market was studied across On-Cloud and On-Premises.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Journey Management in Healthcare & Life Sciences Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Journey Management in Healthcare & Life Sciences Market, including Acoustic, L.P, Acxiom Ltd., Applied Epic, Arena Solutions, AthenaHealth, Cerner, Cisco Systems, Inc., eClinicalWorks, Epic, GMC Software AG, IBM Corporation, Indicative, Inc., InSync Healthcare Solutions, Luma Health, MasterControl, NextGen Healthcare, NICE Systems Inc, Oracle, Pegasystems Inc., Propel, Quadient SA, Qualio, Salesforce.com, inc., SAP SE, Servion Global Solutions Ltd., and Vertafore, Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Journey Management in Healthcare & Life Sciences Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Journey Management in Healthcare & Life Sciences Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Journey Management in Healthcare & Life Sciences Market?
  • 4. What is the competitive strategic window for opportunities in the Global Journey Management in Healthcare & Life Sciences Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Journey Management in Healthcare & Life Sciences Market?
  • 6. What is the market share of the leading vendors in the Global Journey Management in Healthcare & Life Sciences Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Journey Management in Healthcare & Life Sciences Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Define: Research Objective
  • 2.3. Determine: Research Design
  • 2.4. Prepare: Research Instrument
  • 2.5. Collect: Data Source
  • 2.6. Analyze: Data Interpretation
  • 2.7. Formulate: Data Verification
  • 2.8. Publish: Research Report
  • 2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need for consistent patient experience throughout the healthcare journey
      • 5.1.1.2. Demand to gain granular view of the patient journey in life sciences commercialization
      • 5.1.1.3. Dramatic shift towards patient-centric services
    • 5.1.2. Restraints
      • 5.1.2.1. Complications associated with the data synchronization
    • 5.1.3. Opportunities
      • 5.1.3.1. Digitalization increases customer interaction at virtual touchpoints
      • 5.1.3.2. Growing adoption of advanced analytics on patient intents
    • 5.1.4. Challenges
      • 5.1.4.1. Data privacy and security concerns
  • 5.2. Cumulative Impact of COVID-19

6. Journey Management in Healthcare & Life Sciences Market, by Type

  • 6.1. Introduction
  • 6.2. Insurance Journey Management
  • 6.3. Patient Journey Management
  • 6.4. Product Lifecycle Management

7. Journey Management in Healthcare & Life Sciences Market, by Component

  • 7.1. Introduction
  • 7.2. Journey Analytics
  • 7.3. Journey Mapping
  • 7.4. Journey Orchistration

8. Journey Management in Healthcare & Life Sciences Market, by End-User

  • 8.1. Introduction
  • 8.2. Healthcare Patient
  • 8.3. Healthcare Payer
  • 8.4. Healthcare Provider
  • 8.5. Pharmaceutical & Biotechnology Companies

9. Journey Management in Healthcare & Life Sciences Market, by Deployment

  • 9.1. Introduction
  • 9.2. On-Cloud
  • 9.3. On-Premises

10. Americas Journey Management in Healthcare & Life Sciences Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Journey Management in Healthcare & Life Sciences Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand

12. Europe, Middle East & Africa Journey Management in Healthcare & Life Sciences Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Key Player
  • 13.4. Competitive Scenario
    • 13.4.1. Merger & Acquisition
    • 13.4.2. Agreement, Collaboration, & Partnership
    • 13.4.3. New Product Launch & Enhancement
    • 13.4.4. Investment & Funding
    • 13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. Acoustic, L.P
  • 14.2. Acxiom Ltd.
  • 14.3. Applied Epic
  • 14.4. Arena Solutions
  • 14.5. AthenaHealth
  • 14.6. Cerner
  • 14.7. Cisco Systems, Inc.
  • 14.8. eClinicalWorks
  • 14.9. Epic
  • 14.10. GMC Software AG
  • 14.11. IBM Corporation
  • 14.12. Indicative, Inc.
  • 14.13. InSync Healthcare Solutions
  • 14.14. Luma Health
  • 14.15. MasterControl
  • 14.16. NextGen Healthcare
  • 14.17. NICE Systems Inc
  • 14.18. Oracle
  • 14.19. Pegasystems Inc.
  • 14.20. Propel
  • 14.21. Quadient SA
  • 14.22. Qualio
  • 14.23. Salesforce.com, inc.
  • 14.24. SAP SE
  • 14.25. Servion Global Solutions Ltd.
  • 14.26. Vertafore, Inc.

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing